| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
|
Fukada, Ippei
|
|
|
190 |
3 |
p. 425-434
|
artikel
|
| 2 |
Clinical trial representativeness and treatment intensity in a real-world sample of women with early stage breast cancer
|
Rocque, Gabrielle B.
|
|
|
190 |
3 |
p. 531-540
|
artikel
|
| 3 |
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue
|
Lapidari, Pietro
|
|
|
190 |
3 |
p. 517-529
|
artikel
|
| 4 |
Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients
|
Arias-Pulido, Hugo
|
|
|
190 |
3 |
p. 477-489
|
artikel
|
| 5 |
Expression of neurotensin receptor-1 (NTS1) in primary breast tumors, cellular distribution, and association with clinical and biological factors
|
Morgat, Clément
|
|
|
190 |
3 |
p. 403-413
|
artikel
|
| 6 |
Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients
|
Thorén, Linda
|
|
|
190 |
3 |
p. 451-462
|
artikel
|
| 7 |
Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk tools
|
Soliman, Osama
|
|
|
190 |
3 |
p. 355-356
|
artikel
|
| 8 |
Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin
|
Bahrami, Nazli
|
|
|
190 |
3 |
p. 435-449
|
artikel
|
| 9 |
Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase
|
Malin, Dmitry
|
|
|
190 |
3 |
p. 373-387
|
artikel
|
| 10 |
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
|
Cazzaniga, M. E.
|
|
|
190 |
3 |
p. 415-424
|
artikel
|
| 11 |
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1
|
Neirich, Leonie
|
|
|
190 |
3 |
p. 463-475
|
artikel
|
| 12 |
Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer
|
Tejera, David
|
|
|
190 |
3 |
p. 491-501
|
artikel
|
| 13 |
Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis
|
Lorona, Nicole C.
|
|
|
190 |
3 |
p. 549-558
|
artikel
|
| 14 |
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes
|
Teinturier, Romain
|
|
|
190 |
3 |
p. 389-401
|
artikel
|
| 15 |
Sleep medication use and risk of fractures in breast cancer survivors
|
Haque, Reina
|
|
|
190 |
3 |
p. 541-548
|
artikel
|
| 16 |
Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer
|
Van Belle, Hannah
|
|
|
190 |
3 |
p. 357-372
|
artikel
|
| 17 |
Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I–III unilateral breast cancer in the USA, 1998–2016
|
Yang, Yinlong
|
|
|
190 |
3 |
p. 503-515
|
artikel
|
Tijdschrift beschrijving